Trial intelligence / Profile preview

Impact of Adjuvant Chemotherapy on Cardiovascular Autonomic Regulation in Colon Cancer

NCT03213444Completed

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start
Jul 2015
Primary completion
Jul 2017
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Open-label trial of oxaliplatin in colon cancer (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Cardiac function evaluation at 6 months. Started Jul 2015; status: completed.

02

Drugs

oxaliplatin
03

Conditions

colon cancer

Beyond the preview

Go deeper on NCT03213444.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03213444.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call